[go: up one dir, main page]

FR2873370B1 - Derives d'acylaminothiazole, leur preparation et leur application en therapeutique - Google Patents

Derives d'acylaminothiazole, leur preparation et leur application en therapeutique

Info

Publication number
FR2873370B1
FR2873370B1 FR0408115A FR0408115A FR2873370B1 FR 2873370 B1 FR2873370 B1 FR 2873370B1 FR 0408115 A FR0408115 A FR 0408115A FR 0408115 A FR0408115 A FR 0408115A FR 2873370 B1 FR2873370 B1 FR 2873370B1
Authority
FR
France
Prior art keywords
preparation
therapeutic application
acylaminothiazole derivatives
acylaminothiazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0408115A
Other languages
English (en)
Other versions
FR2873370A1 (fr
Inventor
Sylvie Baltzer
Dorsselaer Viviane Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0408115A priority Critical patent/FR2873370B1/fr
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Priority to AU2005209442A priority patent/AU2005209442B2/en
Priority to CN2005800050955A priority patent/CN1930155B/zh
Priority to PCT/FR2005/000032 priority patent/WO2005073226A1/fr
Priority to JP2006548342A priority patent/JP2007517840A/ja
Priority to BRPI0506880-0A priority patent/BRPI0506880A/pt
Priority to NZ548531A priority patent/NZ548531A/en
Priority to RU2006129642/04A priority patent/RU2401262C2/ru
Priority to CA002551142A priority patent/CA2551142A1/fr
Priority to EP05717380A priority patent/EP1709041A1/fr
Priority to ARP050100129A priority patent/AR047387A1/es
Priority to TW094101173A priority patent/TWI340642B/zh
Publication of FR2873370A1 publication Critical patent/FR2873370A1/fr
Priority to MA29119A priority patent/MA28233A1/fr
Priority to IL176701A priority patent/IL176701A/en
Priority to US11/456,123 priority patent/US7582664B2/en
Priority to NO20063675A priority patent/NO20063675L/no
Application granted granted Critical
Publication of FR2873370B1 publication Critical patent/FR2873370B1/fr
Priority to HK07109706.9A priority patent/HK1104542A1/xx
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0408115A 2004-01-16 2004-07-22 Derives d'acylaminothiazole, leur preparation et leur application en therapeutique Expired - Fee Related FR2873370B1 (fr)

Priority Applications (17)

Application Number Priority Date Filing Date Title
FR0408115A FR2873370B1 (fr) 2004-07-22 2004-07-22 Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
EP05717380A EP1709041A1 (fr) 2004-01-16 2005-01-07 Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
PCT/FR2005/000032 WO2005073226A1 (fr) 2004-01-16 2005-01-07 Derives d’acylaminothiazole, leur preparation et leur application en therapeutique
JP2006548342A JP2007517840A (ja) 2004-01-16 2005-01-07 アシルアミノチアゾール誘導体、それらの調製方法及び治療における該誘導体の使用
BRPI0506880-0A BRPI0506880A (pt) 2004-01-16 2005-01-07 derivados de acilaminotiazol, sua preparação e sua aplicação em terapêutica
NZ548531A NZ548531A (en) 2004-01-16 2005-01-07 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
RU2006129642/04A RU2401262C2 (ru) 2004-01-16 2005-01-07 Производные алкиламинотиазола, их получение и их применение в терапии
CA002551142A CA2551142A1 (fr) 2004-01-16 2005-01-07 Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
AU2005209442A AU2005209442B2 (en) 2004-01-16 2005-01-07 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
CN2005800050955A CN1930155B (zh) 2004-01-16 2005-01-07 酰基氨基噻唑衍生物,它们的制备方法与在治疗中的用途
TW094101173A TWI340642B (en) 2004-01-16 2005-01-14 Acylaminothiazole derivatives, preparation and therapeutic application thereof
ARP050100129A AR047387A1 (es) 2004-01-16 2005-01-14 Derivados de acilaminotiazol, su preparacion y su aplicacion en terapeutica
MA29119A MA28233A1 (fr) 2004-01-16 2006-06-19 Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
IL176701A IL176701A (en) 2004-01-16 2006-07-04 History of acylaminoazole, method of preparation and use
US11/456,123 US7582664B2 (en) 2004-01-16 2006-07-07 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
NO20063675A NO20063675L (no) 2004-01-16 2006-08-15 Acylaminotiazolderlvater, fremstillingsmater og anvendelse derav I terapeutika
HK07109706.9A HK1104542A1 (en) 2004-01-16 2007-09-06 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0408115A FR2873370B1 (fr) 2004-07-22 2004-07-22 Derives d'acylaminothiazole, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2873370A1 FR2873370A1 (fr) 2006-01-27
FR2873370B1 true FR2873370B1 (fr) 2006-10-20

Family

ID=34950304

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0408115A Expired - Fee Related FR2873370B1 (fr) 2004-01-16 2004-07-22 Derives d'acylaminothiazole, leur preparation et leur application en therapeutique

Country Status (1)

Country Link
FR (1) FR2873370B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2840899B1 (fr) * 2002-06-12 2005-02-25 Sanofi Synthelabo Derives d'acylaminothiazole, leur preparation et leur utilisation en therapeutique
FR2842523A1 (fr) * 2002-07-17 2004-01-23 Sanofi Synthelabo Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
PL376171A1 (en) * 2002-10-09 2005-12-27 Pfizer Products Inc. Thiazole compounds for the treatment of neurodegenerative disorders

Also Published As

Publication number Publication date
FR2873370A1 (fr) 2006-01-27

Similar Documents

Publication Publication Date Title
MA28575B1 (fr) Derives de la 1-amino-phthalazine, leur preparation , et leur application en therapeutique
MA28734B1 (fr) Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique
FR2854158B1 (fr) Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique
FR2864080B1 (fr) Derives de 1-piperazine-et-1-homopiperazine-carboxylates, leur preparation et leur application en therapeutique
MA28343A1 (fr) Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
FR2866884B1 (fr) Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique
MA29017B1 (fr) Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
FR2854633B1 (fr) Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique
FR2873691B1 (fr) Derives d'amino-piperidine, leur preparation et leur application en therapeutique
MA27049A1 (fr) Derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
FR2843964B1 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
FR2866888B1 (fr) Derives de alkylpiperazine- et alkylhomopiperazine- carboxylates, leur preparation et leur application en therapeutique
FR2882054B1 (fr) Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
FR2850377B1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
MA28720B1 (fr) Derives de tetrahydroisoquinolilsulfonamides, leur preparation et leur utilisation en therapeutique
MA27233A1 (fr) Derives de piperazinylacylpiperidine, leur preparation et leur application en therapeutique
FR2864958B1 (fr) Derive de n-[(1,5-diphenyl-1h-pyrazol-3-yl)methyl] sulfonamide, leur preparation et leur application en therapeutique.
FR2856684B1 (fr) Derives de diphenylpyridine, leur preparation et leur application en therapeutique
FR2866885B1 (fr) Derives de piperidinylalkylcarbamates, leur prepation et leur application en therapeutique
FR2873690B1 (fr) Derives d'oxopiperidine, leur preparation et leur application en therapeutique
FR2885364B1 (fr) Derives d'alkyl-, alkenyl-et alkynylcarbamates, leur preparation et leur application en therapeutique
FR2888847B1 (fr) Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique
FR2881744B1 (fr) Derives de n-[(4,5-diphenyl-2-thienyl)methyl]amine, leur preparation et leur application en therapeutique
FR2880023B1 (fr) Derives de n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine leur preparation et leur application en therapeutique
FR2873693B1 (fr) Derives d'amino-tropane, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20130329